Recurrent Breast Cancer Completed Phase Trials for Exemestane (DB00990)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01153672Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor TherapyTreatment
NCT01385280Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast CancerTreatment